| Literature DB >> 33595197 |
R Kandaswamy1,2, P G Stock1,3, J Miller1, M A Skeans1, J White4, J Wainright4, N T T Kyaw4, S Niederhaus5, A K Israni1,6,7, J J Snyder1,7.
Abstract
The overall number of pancreas transplants decreased slightly, from 1027 in 2018 to 1015, in 2019, up from a nadir of 947 in 2015. However, the number of simultaneous pancreas-kidney transplants (SPKs) increased in 2019, with a corresponding drop in pancreas-after-kidney transplants (PAKs) and pancreas transplants alone (PTAs). New waitlist registrations increased to 1772 in 2019, from 1606 in 2018. This was predominately driven by SPK listings, and those with type 2 diabetes. Waiting time for SPK decreased by 2 months, to a median of 12 months in 2019, but PTA recipient mean waiting time remained substantially higher, at 24 months, in 2018. Both short- and long-term outcomes, including patient survival, kidney graft survival, and acute rejection-free graft survival, have shown consistent improvement over the last decade. Pancreas graft survival data with the uniform definition of allograft failure is being collected by the Organ Procurement and Transplant Network (OPTN) and will be included in a future report. .Entities:
Keywords: Pancreas transplant; pancreas after kidney transplant; pancreas transplant alone; simultaneous kidney pancreas transplant
Mesh：
Year: 2021 PMID： 33595197 DOI： 10.1111/ajt.16496
Source DB: PubMed Journal: Am J Transplant ISSN： 1600-6135 Impact factor: 8.086